Related Experiment Video
Updated: Mar 26, 2026

06:45
Rating L-DOPA-Induced Dyskinesias in the Unilaterally 6-OHDA-Lesioned Rat Model of Parkinson's Disease
Published on: October 4, 2021
3.7K
Pseudobulbar laughter as a levodopa off phenomenon exacerbated by subthalamic deep brain stimulation
P K Chattha1, P E Greene2, Ritesh A Ramdhani3
1Medical University of Lublin, Lublin, Poland.
Journal of Clinical Movement Disorders
|January 21, 2016
Summary
Pseudobulbar affect (PBA), characterized by inappropriate laughter, is a levodopa OFF phenomenon in Parkinson's disease (PD). Subthalamic nucleus deep brain stimulation (STN-DBS) exacerbated this PBA, which was improved by levodopa.
Area of Science:
- Neurology
- Neuroscience
- Movement Disorders
Background:
- Pseudobulbar affect (PBA) is a neurological symptom common in neurodegenerative diseases.
- PBA can manifest as emotional lability, such as crying without subjective emotional experience.
- In Parkinson's disease (PD), PBA may occur during medication 'wearing-off' periods.
Observation:
- A case study involving a Parkinson's disease patient presenting with inappropriate laughter lacking mirth.
- This laughter was identified as a levodopa OFF phenomenon.
- The patient's laughter also worsened with subthalamic nucleus deep brain stimulation (STN-DBS) when not on medication.
Findings:
- The patient's pseudobulbar laughter was a levodopa OFF phenomenon.
- STN-DBS exacerbated the pseudobulbar laughter in the non-medicated state.
- Levodopa administration effectively ameliorated the PBA, both with and without STN-DBS.
Implications:
- This case highlights pseudobulbar laughter as a distinct levodopa OFF phenomenon in PD.
- It suggests STN-DBS can exacerbate PBA, particularly in a non-medicated state.
- Levodopa remains a key therapeutic option for managing PBA in PD patients, even with concurrent DBS.
Related Concept Videos
Parkinson's Disease: Treatment
1.3K
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
1.3K
Parkinson's Disease: Overview
2.4K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
2.4K
Neural Regulation
44.7K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
44.7K

